Surgalign to Sell Global Hardware and Biologics Business

Surgalign entered into an asset purchase agreement to sell substantially all of its U.S. hardware and biomaterials assets and certain equity interests related to the hardware business outside of the U.S. to Xtant Medical for USD $5.0 million. The sale will be effectuated through the Chapter 11 proceedings initiated by the Company and certain of...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us